I don't think there really are any "milestones" for the trials. At this point it's all about the data.
Last I recall the anticipated PII AML trial timeframe was somewhere around 2 years to be complete. The clinicaltrials website has the primary completion date set to July 2022. I know the plan is currently to gain approval based on this PII trial so that's the only timeframe I can see. The trial is open label so the company will be getting the data in real time. How and when they choose to release that data is another topic all together and I don't think we will ever know until it happens. Which is normal.
The pancreatic trial is fully enrolled and has a primary completion date of May 2021. If final data is good then I would assume this will be the next company sponsored PII trial. I don't have any more information than was said by the company which was updates will be shared if and when the company gets them and sees them fit for release. I do have an email out regarding this trial and will update if I get any sort of meaningful response.
News 
Market Data 
Discover 
